Advocacy Actions
China Outlook: 13th Five-Year-Plan
In March 2016, the Chinese Central Government officially released the 13th Five-Year-Plan (FYP). This 13th FYP is China’s master policy blueprint in which the highest levels of the Chinese leadership set out the goals, principles and targets for China’s development in the next five years. Furthermore, it provides orientation for China’s economic and social development and points out the challenges and objectives on deepening reforms and strategies to welcome the “new era” of the Chinese economy. As this will have a significant impact not only on China, but also on the rest of the world, investors should have a closer look at the changes and new reforms to adjust their business operations accordingly.
Read moreComments on CFDA's Draft “Regulatory Guideline on Cold Chain (Transport, Storage) of Medical Devices”
On 06 May, the CFDA has initiated a Public Consultation on the Draft “Regulatory Guideline on Cold Chain (Transport, Storage) of Medical Devices”. In reply, the European Chamber has submitted consolidated comments on this draft regulation.
Read moreMeeting with European Parlimament’s Delegation for Relations with China
The purpose of the meeting with the European Parliament’s Delegation for Relations with China was in order to present China’s business climate, trends/obstacles for EU business in China, progress negotiations Comprehensive Agreement on Investment and overcapacity in China.
Read moreDiscussing with the EU Delegation for the outcomes of the ETWG meeting
A telephone with the EU Delegation for the outcomes of the ETWG meeting
Read moreMeeting with Department of Foreign Capital and Overseas Investment, NDRC
Adam Dunnett, Secretary General of the Chamber leading a delegation met with Deputy Director General Liu Hongkuan at a joint meeting held at the NDRC.
Read moreMeeting with CFDA on EU-China cooperation project - Medical Device Expert Roundtable (MDER)
Meeting with CFDA Medical Device Registration Department for MDER
Read moreMeeting with the NHFPC on the WHO Discussion Paper
The representatives of the PN Desk had a meeting with the NHFPC regarding the WHO Guidance on ending the inappropriate promotion of foods for infants and young children (Discussion Paper).
Read moreLobby Letter to Drug Registration Department of the CFDA on Registration of Chemoluminescent Blood Screening Products
The Healthcare Equipment Working Group of the European Chamber Sent a Lobby Letter to the Department of Drug Registration of the CFDA to ask for acceptance of submissions for registration of chemoluminescent blood screening product.
Read moreEuropean Chamber Comments on SPB's Administrative Regulations for Security Inspection Device of Micro-Dose X-Ray for Express Mails
European Chamber Comments on SPB's Administrative Regulations for Security Inspection Device of Micro-Dose X-Ray for Express Mails
Read moreEuropean Chamber Comments on Administrative Procedure for Operation Assessment of Foreign Air Carriers Engaged in Common Carriage
On May 8, the European Chamber Aviation and Aerospace Working Group submitted comments on the “Administrative Procedure for Operation Assessment of Foreign Air Carriers Engaged in Common Carriage" to Civil Aviation Administration of China.
Read more